Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

Recruiting N/A Interventional Study
Low-grade Glioma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
117 (estimated)
Sponsor
University of California, San Francisco · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Patients with glial brain tumors have increasingly improved outcomes, with median survival of 5-15 years. However, the treatments, including surgery, radiation, and chemotherapy, often lead to impaired attention, working memory, and other cognitive functions. These cognitive deficits frequently have significant impact on patient quality of life. Although currently, there is no established standard…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Arm 1: Inclusion Criteria: * Histologically confirmed low grade supratentorial primary brain tumor * \>= 18 years old * Life expectancy \> 12 weeks * Karnofsky performance status (KPS) \>= 70 * Must speak and be able to read English fluently * Must have access to the internet * Must have text enab…
Contacts

Jennie Taylor, MD, MPH

415-353-2966

jennie.taylor@ucsf.edu

CONTACT